Kathleen Clarence-Smith

-

Director Information, Funds, Firms

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Kathleen Clarence-Smith
Firm
Addressc/o Chase Therapeutics Corporation 1825 K Street NW, Suite 510
Washington, DC 20006
Source
Associated Funds Form D Role 2011 - 2026 Raised AUM
Chase Therapeutics Corp 021-320230 Director
4.0 M
of 4.0 M
GT Biopharma Inc 021-319563 Director
5.1 M
of 5.1 M
GT Biopharma Inc 021-304968 Director
7.1 M
of 7.1 M
Chase Therapeutics Corp 021-299627 Director
1.3 M
of 1.3 M
GT Biopharma Inc 021-294767 Executive Officer
4.5 M
of 4.5 M
Chase Pharmaceuticals Corp 021-260084 Executive Officer
12.0 M
of 12.0 M
Chase Pharmaceuticals Corp 021-257591 Executive Officer

of 0.1 M
Chase Pharmaceuticals Corp 021-257589 Executive Officer

of 0.6 M
Chase Pharmaceuticals Corp 021-246193 Executive Officer
3.5 M
of 3.5 M
Chase Pharmaceuticals Corp 021-153008 Executive Officer
1.2 M
of 1.2 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com